Vanda Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Washington, DC
SEC filing record 1 source field available
Fiscal year end
31 December
Vanda Pharmaceuticals Inc. has filed 1,327 SEC EDGAR filings since 29 Dec 2005

SEC filing history

Showing 1-18 of 18 matching filings.

Per page
25
Current page
1
10-K/A File 001-34186

FORM 10-K (AMENDMENT NO. 1)

Filing date
10 Jun 2015
Reporting date
31 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-34186

10-K

Filing date
10 Mar 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-34186

FORM 10-K

Filing date
15 Mar 2010
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .